COVID-19 Cure and Artificial Intelligence: Andrew Satz CEO of EVQLV

Traditional wet lab approaches to find a cure for COVID-19 could take decades. Using artificial intelligence, Andrew Satz and Brett Averso are saving ImmunoPrecise Antibodies years on years and millions of dollars in an attempt to find a novel coronavirus antibody. Where Brett concentrated on the technology for our listeners, Andrew adds his CEO view on the problem they're tackling. 

We publish another ad-hoc COVID-19 episode for our audience, as we all work towards solutions to this pandemic. 

Anybody working on COVID-19 tracking and cures, please let us know. We'd love to have you on and build awareness of your efforts. Email us, tweet at us, send us basket carrying Shar-Pei couriers. 

Please be safe! Remember, we're urging everyone to act in a predictive way. Current state is not necessarily our future reality.